What's Wrong With UnitedHealth Stock?

Impact · against what's priced in

UnitedHealth Group faces a significant negative catalyst as it confronts a potential first annual revenue contraction in 30 years and a severe shortfall in government Medicare Advantage payment rates for 2027. These fundamental headwinds to top-line growth and margins suggest a structural shift in the company's growth trajectory.

UNH−0.80

No priced-in read yet

In context

The proposed 2027 Medicare Advantage payment increase of less than 0.1% is drastically lower than the 4-6% analyst expectations, hitting the company's 29% market share. Additionally, a 2026 revenue outlook of $439 billion—$15 billion below expectations—signals a possible first revenue contraction in over three decades.

• government spendingNew
• earnings
• guidance
• healthcare
• UNH
• health insurance
• medicare advantage
• revenue contraction

Top 1 mover · tap to explore